CD4 and neoplasm: In this study, we found that cDHPs inhibited the growth of lung adenocarcinoma (LUAD) transplants in mice and prevented the conversion of CD4+ T cells into IL-35-producing induced regulatory T cells (iTr35) to activate anti-tumor immunity by inhibiting the FXR1-IL-35 axis.